clopidogrel

The drug is used for the secondary prevention of atherothrombotic complications in adults. It is prescribed to continue therapy in cases of acute coronary syndrome (unstable angina or myocardial infarction) and acute ST-segment elevation myocardial infarction.

Form: capsules

ATC: B01AC30

Manufacturer: Mepro Pharmaceuticals Private Limited

The drug is used for the prevention of atherothrombosis manifestations in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for acute coronary syndrome and for the prevention of thromboembolic events in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: JSC "Kyiv Vitamin Plant"

The drug is used for the prevention of atherothrombosis in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for acute coronary syndrome and for the prevention of complications in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: LLC "Pharmaceutical Company "Zdorovya" (manufacturing from bulk product of LLC "FARMEKS GROUP", Ukraine)

The drug is used for the prevention of cardiovascular events in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for acute coronary syndrome, transient ischemic attack (TIA), or minor ischemic stroke, as well as for the prevention of thromboembolic events in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: PJSC "Scientific and Production Center "Borshchahivskyy Chemical and Pharmaceutical Plant"

The drug is used for the prevention of atherothrombotic events in adults who have suffered myocardial infarction, ischemic stroke, or have peripheral arterial disease. It is also prescribed for the prevention of thromboembolic events in atrial fibrillation (in combination with acetylsalicylic acid).

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: LLC "Research Plant "GNCLS" (all manufacturing stages, quality control, batch release)

The drug is used for the prevention of cardiovascular events in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for acute coronary syndrome, transient ischemic attack (TIA), or minor stroke, as well as for the prevention of thrombosis in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Ananta Medikear Limited

The drug is used for the prevention of atherothrombotic events in adults who have suffered myocardial infarction, ischemic stroke, or have peripheral arterial disease. It is also prescribed for acute coronary syndrome and for the prevention of thromboembolic events in patients with atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Macleods Pharmaceuticals Limited

The drug is used for the prevention of atherothrombotic events in adults who have suffered myocardial infarction, ischemic stroke, or have peripheral arterial disease. It is also prescribed for the prevention of thromboembolic events in atrial fibrillation (in combination with acetylsalicylic acid).

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Farmex Group LLC

The drug is used for the prevention of atherothrombosis in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral arterial disease. It is also prescribed for acute coronary syndrome, transient ischemic attack (TIA), and for the prevention of thromboembolic events in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Sanofi Winthrop Industries

The drug is used for the prevention of atherothrombotic complications in adults who are already receiving therapy with clopidogrel and acetylsalicylic acid. It is prescribed to continue treatment after acute coronary syndrome or acute myocardial infarction.

Form: capsules, hard

ATC: B01AC30

Manufacturer: MNPC "Mikrokhim" LLC (legal address; conducting tests within the scope of quality control (physical/chemical tests); production unit; responsible for batch release, excluding control/testing of the batch)

The drug is used for the secondary prevention of atherothrombotic complications in adults who are already taking clopidogrel and acetylsalicylic acid. It is prescribed for acute coronary syndrome (unstable angina or non-ST-segment elevation myocardial infarction) and for acute ST-segment elevation myocardial infarction.

Form: tablets, film-coated

ATC: B01AC30

Manufacturer: Sanofi Winthrop Industries

The drug is used for the prevention of cardiovascular events in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for acute coronary syndrome, transient ischemic attack (TIA), or minor ischemic stroke, as well as for the prevention of thromboembolic events in patients with atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Medocemi Limited (manufacturing of unpackaged product, quality control, batch release; primary and secondary packaging)

The drug is used for the prevention of cardiovascular events in adults who have suffered myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for the prevention of thrombosis in patients with atrial fibrillation in combination with acetylsalicylic acid.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Aurobindo Pharma Limited (Unit III)

The drug is used for the prevention of atherothrombotic events in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral arterial disease. It is also prescribed for acute coronary syndrome and for the prevention of thromboembolic events in atrial fibrillation (in combination with acetylsalicylic acid).

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO – 3

The drug is used for the prevention of atherothrombosis manifestations in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for acute coronary syndrome, transient ischemic attack (TIA), and for the prevention of thromboembolic events in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: KUSUM PHARM LLC (manufacturing, primary packaging, secondary packaging, quality control, batch release or secondary packaging, quality control, batch release of products in bulk)

The drug is used for the prevention of cardiovascular events in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for acute coronary syndrome, moderate-to-high-risk transient ischemic attack (TIA) or minor ischemic stroke, as well as for the prevention of thromboembolic events in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Sanofi Winthrop Industries

The drug is used for the prevention of atherothrombotic events in adults who have suffered myocardial infarction, ischemic stroke, or have peripheral arterial disease. It is also prescribed for acute coronary syndrome, moderate-to-high-risk transient ischemic attack (TIA), and for the prevention of thromboembolic events in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Sanofi Winthrop Industries

The drug is used for the prevention of atherothrombotic events in adults who have suffered a myocardial infarction, ischemic stroke, or have peripheral artery disease. It is also prescribed for acute coronary syndrome, transient ischemic attack (TIA), and for the prevention of thromboembolic events in atrial fibrillation.

Form: tablets, film-coated

ATC: B01AC04

Manufacturer: Farmak JSC